GRDN · Guardian Pharmacy Services, Inc. · Earnings Call Transcripts & Audio
$40.78
+0.10 (+0.25%)
At close · Sep 30
Return incl. dividend (before tax)
Market Cap
$2.61B
Shares
63.34M
Volume · Sep 30
540.21K
Avg daily vol (3M)
477.5K
Guardian Pharmacy Services, Inc. Earnings Call Transcripts
Quarterly earnings calls for Guardian Pharmacy Services, Inc. (GRDN), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲19.7%
$314.39M
−$121.99M
'24 Q3
24-11-12
·
$338.57M
$4.85M
'24 Q4
25-03-26
▲19.6%
$329.31M
$9.45M
'25 Q1
25-05-12
▲14.8%
$344.33M
$9.03M
'25 Q2
25-08-11
▲20%
$377.43M
$9.82M
'25 Q3
25-11-10
▲17.4%
$397.62M
$20.92M
'25 Q4
26-03-11
▲2.2%
$336.60M
$13.29M
'26 Q1
26-05-06
LATEST
▲2.2%
$351.77M
$21.87M
'26 Q2
26-08-06
Conference
Investor event
2026-09-15
Guardian Pharmacy Services, Inc. (GRDN) September 2026 Conference
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-09-15
Guardian Pharmacy Services, Inc. (GRDN) September 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-08-06
Guardian Pharmacy Services, Inc. (GRDN) Q2 2026 Earnings Call Transcript
Revenue
$351.77M
▲ 2.2% YoY Gross margin
22.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-06
Guardian Pharmacy Services, Inc. (GRDN) Q1 2026 Earnings Call Transcript
Positive tone
IRA transition and drug pricing impact
Gross profit and EBITDA results
M&A pipeline and national accounts
Revenue
$336.60M
▲ 2.2% YoY Gross margin
22.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-11
Guardian Pharmacy Services, Inc. (GRDN) Q4 2025 Earnings Call Transcript
Confident tone
Inflation Reduction Act (IRA) Impact
Vaccine Clinics
Clinical Value and Interventions
Revenue
$397.62M*
▲ 17.4% YoY Gross margin
21.5%
Rev · 7q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-10
Guardian Pharmacy Services, Inc. (GRDN) Q3 2025 Earnings Call Transcript
Positive tone
Acquisitions and Greenfields
Margin Pressure from New Pharmacies
Revenue and EBITDA Growth
Revenue
$377.43M
▲ 20% YoY Gross margin
19.8%
Rev · 7q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-11
Guardian Pharmacy Services, Inc. (GRDN) Q2 2025 Earnings Call Transcript
Confident tone
Acquisitions and Greenfields
Growth and Guidance Raise
Margin Pressure from M&A Integration
Revenue
$344.33M
▲ 14.8% YoY Gross margin
19.8%
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-12
Guardian Pharmacy Services, Inc. (GRDN) Q1 2025 Earnings Call Transcript
Confident tone
Revenue and EBITDA Growth
Acquisitions and Integration
Tariff Impact Assessment
Revenue
$329.31M
▲ 19.6% YoY Gross margin
19.5%
Rev · 5q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-26
Guardian Pharmacy Services, Inc. (GRDN) Q4 2024 Earnings Call Transcript
Confident tone
Revenue and EBITDA growth
M&A and greenfield expansion
Inflation Reduction Act risk
Revenue
$338.57M*
Gross margin
19.8%
Rev · 4q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-12
Guardian Pharmacy Services, Inc. (GRDN) Q3 2024 Earnings Call
Revenue
$314.39M
▲ 19.7% YoY Gross margin
19.4%
Rev · 4q
Audio
Transcript
Slides
8-K10-Q
Showing 1–10 of 10 earnings calls